How Could "Grand Challenges" Investments Solve the Hardest Problems in Biotechnology?
June 18, 2025
Special Program
Biomanufacturing
210B
Breakthroughs in biomanufacturing, biochemical modeling, and AI-enabled drug discovery and development could dramatically boost industry-wide productivity—but they require massive early-stage investments that are currently too risky for many private firms to undertake alone. The NSCEB urges the U.S. government to launch a national research agenda and seed funding effort to tackle "grand challenges" like these.
Moderator
Vice President, National Security & International Affairs
Biotechnology Innovation Organization (BIO)
Speakers
Policy Advisor, Office of the Special Envoy for Critical and Emerging Technology (S/TECH)
U.S. Department of State
Raymond A. (1921) and Helen E. St. Laurent Professor of Chemical Engineering
Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
Senior Policy Advisor
National Security Commission on Emerging Biotechnology (NSCEB)
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}